NBY
AMEX · Pharmaceuticals
Novabay Pharmaceuticals Inc
$1.27
+0.27 (+27.00%)
Open$1.00
Previous Close$1.00
Day High$1.28
Day Low$0.94
52W High$99.75
52W Low—
Volume—
Avg Volume3.16M
Market Cap51.92M
P/E Ratio—
EPS$-4.09
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 117.75M | 112.01M | 19.57M |
| Net Income | -86,949,597 | -74,443,148 | 4.44M |
| Profit Margin | -73.9% | -70.2% | 22.7% |
| EBITDA | -86,095,187 | -77,806,723 | 7.02M |
| Free Cash Flow | — | — | 4.00M |
| Rev Growth | +5.1% | +5.1% | -0.9% |
| Debt/Equity | 0.34 | 0.34 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |